Panthera Biopartners (Panthera) is the UK’s largest Site Management Organisation (SMO) for commercial clinical trials.
Based in Preston, Lancashire, Panthera specialises in the recruitment of patients and running of Phase II and Phase III clinical trials across a broad spectrum of therapeutic areas including vaccines, cardiovascular medicine, diabetes, neurology, respiratory medicine, dermatology, rheumatology and early dementia trials. Its service offering spans trial planning, data collection and patient retention. It operates six UK sites and provides clinical trials for many of the largest pharmaceutical companies and clinical research organisations (CROs) globally.
Scaling and expanding
In August 2025, LDC backed Panthera’s existing management team, led by CEO Stuart Young, CCO Chris Dodd, CFO Rory Lloyd, CMO Dr. Mahadev Ramjee and CIO Andy Broomhead, to support an ambitious growth strategy underpinned by further expanding its operations in the UK and Europe, increasing its number of clinical sites, investing in technology, and scaling its trial delivery capabilities.
